Canada The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the top spot with USD 3.46 billion, followed by AbbVie at 1.34 billion and Novartis at 1.32 billion. Made with Visme Infographic Maker
Canada Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics, pharmaceutical and biologics spending, production costs, and pricing changes. Canada pharma data overview. Made with Visme Infographic Maker Pharmaceutical spending as a percentage of GDP in Canada (international comparison). Made with Visme Infographic Maker …
Canada In total there were 27 new active substances (NASs) approved in Canada in 2018, 18 prescription pharmaceutical drugs and 9 biologics. In terms of companies that saw particular success last year, Merck (MSD outside of the US and Canada) had three prescription drugs approved, as did Swiss-headquartered Vifor Pharma. Global…
Canada The Top 10 bestselling patented medicines in Canada for 2017. Janssen sold CND 938.1 million of its Remicade treatment for gastroenterology, rheumatology and dermatology indications, making up a full 5.6% of all patented medicine sales in Canada. In second place was Abbvie’s Humira with CND 701.9 million of sales and…
Canada Canada’s medical cannabis market is valued as a USD 1.3 billion market opportunity, with the recreational market potential worth over USD eight billion. Ontario is the Canadian state with by far the largest number of licensed cannabis producers with 57 compared to just 22 in second-placed British Colombia and seven…
Canada Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs. Key areas of expenditure in Canadian medtech: diagnostic imaging stands as the single largest therapeutic area served. Canadian medical device export destinations; the US is far and away the largest market for Canadian…
Pharma The top 10 pharmaceutical companies in Canada for 2016 in terms of total sales and market share. Johnson & Johnson leads the way with USD 2.93 billion in sales, followed by Novartis with USD 1.24 billion and TEVA with USD 1.19 billion.
Canada This graph shows Quebec’s R&D expenditure as a percentage of GDP, in comparison to other provinces in Canada, as well as other OECD countries.
See our Cookie Privacy Policy Here